Remove HIPAA Remove Pharmaceutical Companies Remove Presentation
article thumbnail

AI-Powered Pharma Marketing: What 2025 Has in Store

Pharma Marketing Network

Introduction Artificial Intelligence (AI) is no longer just a futuristic concept in pharmaceutical marketingits the present and future. In 2025, AI-powered pharma marketing is transforming how companies engage healthcare professionals (HCPs), patients, and stakeholders. Is AI secure enough for patient engagement?

article thumbnail

Why Healthcare is Seeing an Increase in 2025 Ad Budgeting

Pharma Marketing Network

With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. Regulatory agencies are demanding clearer disclosures and evidence-based claims in pharmaceutical promotions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Three Ways Pharma Advertisers Can Benefit from Attention Metrics

Pharma Marketing Network

Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of third-party cookies, which all marketers must consider. Even brilliant creative is unlikely to attract attention when presented in a low-quality placement.

article thumbnail

Top Pharma Marketing News and Trends for 2025: Insights for Industry Leaders

Pharma Marketing Network

Pharmaceutical companies are leveraging AI and data analytics to create hyper-personalized campaigns. Navigating HIPAA regulations while tailoring messages requires careful planning and ethical decision-making. Additionally, the rise of social media marketing presents a new regulatory gray area.

article thumbnail

Healthcare data management: resolving consent, compliance, and privacy issues

Pharmaceutical Technology

The multiple platforms and apps used in professional and personal lives present significant challenges for data management systems. Breaches of HIPAA in the US can result in fines of up to $50,000. A prime example of Cassie’s capabilities is a project Fairhurst has been working on for an international pharmaceutical company.

article thumbnail

Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution

The FDA Law Blog

While ensuring that a pre-enforcement challenge is properly presented to a court is not a simple task, it can be done, and for those interested, there may be much to challenge. Nevertheless, individuals and organizations could be in receipt of grand jury or HIPAA subpoenas requesting records, or they could be visited by federal agents.